‘Strange Mix of Bedfellows’: Big Tech, Big Pharma Join MAHA Supporters at First MAHA Summit

But at last week’s MAHA Summit, these same entities and technologies took center stage.

The summit, held in Washington, D.C., brought together representatives of established and startup biomedical and biotechnology firms with key government officials — including U.S. Health Secretary Robert F. Kennedy Jr. — and members of the MAHA grassroots movement.

STAT called it “a strange mix of bedfellows.”

The audience of “Trump administration officials, biotech entrepreneurs, MAHA influencers and others included sessions about topics such as how artificial intelligence is being used in health care, reversing aging, making food healthier and more,” The Associated Press reported.

For some, the presence of Big Tech firms, pharmaceutical companies and large retailers at a MAHA event represents a betrayal of MAHA’s key principles, including its mission to combat the chronic disease epidemic in the U.S. The list of attendees and sponsors evoked criticism from some MAHA supporters.

But for Finn Kennedy, a board member of MAHA Holdings, which organized the summit in partnership with MAHA Action, the summit’s goal was to “accelerate private industry’s adoption of the MAHA agenda and turn that vision of a healthier, more prosperous America into reality.”